HUTCHMED (China) (HMDCF) Gross Margin Growth (1y) (2016 - 2021)
Powered by 
Analysis
HUTCHMED (China) (HMDCF) Gross Margin Growth (1y) (2016 - 2021) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.40 Bn | 197.42 Bn | 7.24 Bn | 484.00 |
| 2 | Gilead Sciences | 181.20 Bn | 178.03 Bn | 6.22 Bn | 96.00 |
| 3 | Vertex Pharmaceuticals | 132.13 Bn | 124.28 Bn | 2.84 Bn | -93.00 |
| 4 | Regeneron Pharmaceuticals | 82.53 Bn | 74.53 Bn | 3.93 Bn | -91.00 |
| 5 | Argenx Se | 61.72 Bn | 56.54 Bn | 1.37 Bn | 210.00 |
| 6 | Moderna | 54.67 Bn | 49.53 Bn | 52.00 Mn | 1,966.00 |
| 7 | Alnylam Pharmaceuticals | 34.13 Bn | 30.82 Bn | 992.69 Mn | -475.00 |
| 8 | Biogen | 31.29 Bn | 30.00 Bn | 1.96 Bn | -553.00 |
| 9 | Roivant Sciences | 30.03 Bn | 30.03 Bn | 1.16 Mn | -1,260.00 |
| 10 | HUTCHMED (China) | 376.85 Mn | 391.04 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2021 | -1,005.00 |
| Jun 30, 2020 | 422.00 |
| Mar 31, 2020 | 1,854.00 |
| Dec 31, 2019 | -30,038.00 |
| Sep 30, 2019 | 18,264.00 |
| Jun 30, 2019 | -17,916.00 |
| Mar 31, 2019 | 156.00 |
| Jun 30, 2016 | 1,229.00 |